Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases

Yu Chen1, Brian Shoichet, Richard Bonnet

  • 1Department of Pharmaceutical Chemistry, University of California, San Francisco, Genentech Hall, 600 16th Street, San Francisco, California 94143-2240, USA.

Insights

CTX-M enzymes, a major cause of antibiotic resistance, were studied using X-ray crystallography. Researchers identified key structural changes and a novel inhibition mechanism, paving the way for new drug designs against resistant bacteria.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Microbiology

Background:

  • CTX-M enzymes are a significant and growing group of extended-spectrum beta-lactamases (ESBLs).
  • These enzymes confer resistance to penicillins and various generations of cephalosporins.
  • Effective inhibitors and detailed mechanistic understanding of CTX-M enzymes are limited.

Purpose of the Study:

  • To elucidate the detailed mechanism of CTX-M enzymes.
  • To characterize the enzyme's reaction coordinate using X-ray crystallography.
  • To provide structural templates for designing novel inhibitors against CTX-M-mediated antibiotic resistance.

Main Methods:

  • X-ray crystal structures of CTX-M enzymes.
  • Complex formation with transition-state analogues and beta-lactam inhibitors.
  • Analysis of enzyme conformational changes along the reaction coordinate.

Main Results:

  • Observed conformational changes in catalytic residues Lys73 and Glu166.
  • Discovered that cefoxitin's 7alpha-methoxy group inhibits by sterically hindering deacylation, not by displacing catalytic water.
  • Identified a ceftazidime-like boronic acid inhibitor with a 4 nM K(i) value against CTX-M-16.
  • Demonstrated reversal of cefotaxime resistance in bacteria using the boronic acid inhibitor.

Conclusions:

  • The study provides a detailed structural view of the CTX-M enzymatic mechanism.
  • The findings offer insights into inhibitor design strategies targeting CTX-M enzymes.
  • Structural data can guide the development of new interventions against antibiotic resistance conferred by CTX-M enzymes.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...